Michael W Pride

Title: Michael W. Pride: Innovator in Hepatitis B Research

Introduction

Michael W. Pride is a notable inventor based in Buffalo, NY (US), recognized for his significant contributions to the field of immunology, particularly in the development of vaccines against the hepatitis B virus. With a total of four patents to his name, Pride's work has advanced the understanding and treatment of hepatitis B, a critical public health issue.

Latest Patents

Among his latest patents, one includes a method of immunizing against the hepatitis B virus. This method involves administering a vaccine that contains a hepatitis B virus surface antigen, which includes one or more antigens of non-permitted variant sequences within specific residues of the surface antigen. Another significant patent focuses on raising an immune response using an anti-idiotypic antibody designated 2F10. This invention comprises the antibody and its permitted variants, which exhibit antigenic properties similar to the group specific 'a' determinant of human hepatitis B surface antigen. Additionally, it includes a peptide chain with specific amino acid residues that also demonstrate similar properties.

Career Highlights

Michael W. Pride has worked with reputable organizations such as Health Research, Inc. and University College London. His career reflects a commitment to advancing medical research and developing innovative solutions to combat viral infections.

Collaborations

Pride has collaborated with esteemed colleagues, including Yasmin M. Thanavala and Arvind Thakur, contributing to a rich exchange of ideas and expertise in the field of immunology.

Conclusion

Michael W. Pride's innovative work in hepatitis B research exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations continue to pave the way for advancements in vaccine development and immunotherapy.